1,182 results
Page 4 of 60
8-K
z4mmsj5 rh7kg
7 May 24
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:02am
PRE 14A
9pf60hsq3j7pfwhr7
3 May 24
Preliminary proxy
5:25pm
8-K
i636dad7
2 May 24
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
4:26pm
NT 20-F
gqf6szrku0 difnc632
30 Apr 24
Notice of late annual filing (foreign)
5:27pm
8-K
3b60w9tasc21pza
29 Apr 24
Biote Announces Definitive Settlement with Founder
4:24pm
6-K
sd5veo3ai01wv
26 Apr 24
Notice of Meeting and Record Date
8:10am
6-K
52r2z6efw 39
25 Apr 24
Akanda Appoints Cooper to the Board of Directors
9:17pm
ARS
h8keqdj
16 Apr 24
Annual report to shareholders
7:14pm
DEFA14A
nldfhrtt
16 Apr 24
Additional proxy soliciting materials
5:26pm
6-K
h0d1y5dc
15 Apr 24
Akanda Announces No Equity Financing Until Further Notice
1:24pm
6-K
o8zr5e9fehu7
12 Apr 24
Report of Foreign Private Issuer
1:39pm
ARS
3lmq2i2ynh6bl
11 Apr 24
Annual report to shareholders
4:29pm
DEFA14A
rsoxw4
11 Apr 24
Additional proxy soliciting materials
4:21pm
6-K
51z8402jbap8rjld7ml
11 Apr 24
Akanda Corp. Announces Closing of the Sale of RPK
1:33pm
8-K
ksoqftv54fga g9
11 Apr 24
Entry into a Material Definitive Agreement
7:03am